Search

everythinglearnresearchcommunity

for

Search:↓

Turkish women with hirsutism experience lower quality of life, especially those with PCOS, regardless of hair growth severity.

Frontal fibrosing alopecia is a scarring hair loss condition mainly affecting older women, with no known cause and treatments that may help stabilize hair loss.

Certain gene variants are linked to a higher risk of polycystic ovary syndrome, hair loss, and obesity in women from western Saudi Arabia.

Fenugreek seed extract in a nanoparticle gel could be a promising new treatment for hair loss.

Hair loss in men might be linked to programmed cell death.

Female pattern hair loss is more common among Indian women than previously believed.

The Pemphigus Disease Area Index and Autoimmune Bullous Skin Disorder Intensity Score are the best tools for assessing pemphigus severity.

Nepalese patients with hair loss, especially women and those with androgenetic alopecia, experience a significant decrease in quality of life.

Hair loss from alopecia areata and androgenetic alopecia moderately affects the quality of life, especially in younger patients and those with long-term hair loss, impacting both their physical and emotional well-being.

Mycophenolate mofetil was effective for most patients in treating scarring hair loss, but some had side effects.

Laser hair removal improves quality of life but emotional benefits decrease over time, suggesting more treatments are needed for lasting effects.

Men with early hair loss have similar hormone levels to women with PCOS, possibly increasing risk of obesity and heart issues.

CLASI is a valid tool for assessing skin activity and damage in lupus patients.

Women with female pattern hair loss have higher levels of certain androgens, suggesting increased androgen exposure to hair follicles.

Spironolactone may help reduce hair growth and testosterone levels in some women with hirsutism.

Low-level laser therapy may reduce symptoms and increase hair thickness in lichen planopilaris patients.

Scalp involvement is common in pemphigus and can lead to hair loss, with the severity of scalp lesions linked to overall disease severity.

Some men with early hair loss may have similar hormonal changes to women with Polycystic ovary syndrome, and could be at risk for developing type 2 diabetes.

People with early hair loss may have a higher chance of enlarged prostate and metabolic syndrome, so they should be checked for urinary and metabolic issues.

Skin problems like acne and excess hair in PCOS are common and linked to being overweight.

Obesity may worsen hair loss in men and increase hirsutism in overweight or obese individuals, with weight loss recommended for treatment.

Canrenone effectively reduced hair growth and testosterone levels in women with excessive hairiness.

Middle-aged women with PCOS often continue to experience symptoms related to high androgen levels, like unwanted hair growth.

Clinical signs of hyperandrogenism are related to female pattern hair loss severity, but biochemical markers are not.

Women with more body hair tend to have thicker belly fat and more metabolic health issues.

Using 5α-reductase inhibitors for hair loss can cause lasting sexual, physical, mental, and vascular health issues in men, even after stopping the medication.

Men with early hair loss may have higher insulin resistance and should be checked for related health issues.

Women with PCOS often have more body hair, acne, and skin darkening, and these signs are linked to metabolic issues like insulin resistance and high cholesterol.

Finasteride doesn't reduce sexual function in people with hair loss.

Finasteride helps hair loss patients' quality of life.